21.38
0.69 (3.33%)
Penutupan Terdahulu | 20.69 |
Buka | 20.76 |
Jumlah Dagangan | 470,502 |
Purata Dagangan (3B) | 555,657 |
Modal Pasaran | 1,016,858,432 |
Harga / Pendapatan (P/E Ke hadapan) | 250.00 |
Harga / Jualan (P/S) | 11.67 |
Harga / Buku (P/B) | 2.97 |
Julat 52 Minggu | |
Tarikh Pendapatan | 6 Aug 2025 - 11 Aug 2025 |
Margin Keuntungan | -11.86% |
Margin Operasi (TTM) | -5.09% |
EPS Cair (TTM) | -0.190 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 29.90% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 7.64% |
Nisbah Semasa (MRQ) | 4.73 |
Aliran Tunai Operasi (OCF TTM) | 14.63 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 39.10 M |
Pulangan Atas Aset (ROA TTM) | -0.79% |
Pulangan Atas Ekuiti (ROE TTM) | -2.52% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Instruments & Supplies (US) | Menurun | Bercampur |
Medical Instruments & Supplies (Global) | Menurun | Menurun | |
Stok | BioLife Solutions, Inc. | Menurun | Menaik |
AISkor Stockmoo
Konsensus Penganalisis | 1.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 4.5 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | 2.0 |
Purata | 2.63 |
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs. |
|
Sektor | Healthcare |
Industri | Medical Instruments & Supplies |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 2.87% |
% Dimiliki oleh Institusi | 102.70% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Cramer Rosenthal Mcglynn Llc | 31 Dec 2024 | 905,752 |
Julat 52 Minggu | ||
Median | 30.00 (40.32%) | |
Jumlah | 1 Beli |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
HC Wainwright & Co. | 13 May 2025 | 30.00 (40.32%) | Beli | 23.09 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
14 May 2025 | Pengumuman | BioLife Solutions to Participate in Upcoming Investor Conferences in May and June 2025 |
08 May 2025 | Pengumuman | BioLife Solutions Updates Earnings Call Information |
08 May 2025 | Pengumuman | BioLife Solutions Reports First Quarter 2025 Financial Results |
30 Apr 2025 | Pengumuman | BioLife Solutions to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025 |
07 Apr 2025 | Pengumuman | BioLife Solutions Acquires PanTHERA CryoSolutions to Advance Leadership as a Pure Play Bioproduction Consumables Company |
18 Mar 2025 | Pengumuman | BioLife Solutions Appoints Cathy Coste as Director and Audit Committee Chair |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |